Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
TARS logo

TARS

NGS
Tarsus Pharmaceuticals Inc.
ManufacturingBiological Product (except Diagnostic) Manufacturing
Watchlists:
Last updated: Monday 14th July 2025
39.18
-1.98 (-4.81%)
Prev Close:41.16
Open:40.7
Bid:37.75
Ask:40.5
52 Week Range
20.08
57.28
Volume:622,861
Mkt Cap:1,668 M
Price Target
$45.06
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

TARS - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Invalid date
Depreciation And Amortization685000.0744000.0325000.0300000.0100000.0
Gain On Sale Of Security-792000.0376000.0-501000.0-987000.0
General And Administrative Expense237 M109 M45 M27 M8 M
Gross Profit Margin (profit Margin After CGS)170 M16 M25 M55 M
Interest Expense Non Operating8 M3 M2 M
Interest Expense Operating2 M
Misc Other Special Charges-1 M-102000.086000.0-73000.0
Net Income (loss)-116 M-136 M-62 M-14 M-27 M
Net Income Common Stockholders-116 M-136 M-62 M-14 M-27 M
Net Income Continuous Operations-116 M-136 M-62 M-14 M-27 M
Net Non Operating Interest Income Expense7 M7 M1 M36000.0188000.0
Normalized Income-120 M
Operating Income-121 M-143 M-63 M-12 M-27 M
Operating Income Before Depreciation (EBITDA)-107 M-132 M-60 M-13 M-27 M
Operating Expense291 M159 M88 M69 M27 M
Other Gand A237 M109 M45 M27 M8 M
Other Impairment Of Capital Assets2000.015000.0
Other Operating Expenses813000.0645000.0-217000.0
Rent And Landing Fees2 M
Research Expense53 M50 M43 M42 M19 M
Selling And Marketing Expense30 M9 M
Total Income Available For Interest Expense (EBIT)-108 M-133 M-60 M-14 M-27 M
Total Revenues183 M17 M26 M57 M
Total Expenses291 M159 M89 M71 M27 M
Total Revenue183 M17 M26 M57 M
Write Off955000.0
Amord9 M4 M174000.0
Avgshs38 M29 M25 M21 M6 M
Avgshsdt38 M29 M25 M21 M
Basiceps-3.07-4.62-2.52-0.67-4.32
Basicepscont-3.07-4.62-2.52-0.67-4.32
Cor955000.02 M
Depamor325000.0300000.0100000.0
Dileps-3.07-4.62-2.52-0.67-4.32
Dilepscont-3.07-4.62-2.52-0.67
Intinc15 M10 M3 M36000.0188000.0
Netincdisc-116 M-136 M-62 M-14 M-27 M
Othincexp2 M-274000.0-683000.02 M15000.0
Pretaxinc-116 M-136 M-62 M-14 M-27 M
Resdev53 M50 M43 M42 M19 M
Sga237 M109 M45 M27 M8 M
Shsout38 M34 M27 M21 M21 M
Specincchg-955000.0
Taxprov-4 M-4 M-4000.055000.01000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader